IBM (NYSE:IBM) plans to develop and apply machine learning techniques to years of research data in the hopes of identifying factors that trigger the onset of Type I diabetes in children, with the support of JDRF.
Scientists at IBM are slated to assess three different data sets using machine learning algorithms to find patterns and factors that could one day help delay or prevent Type I diabetes.
Get the full story at our sister site, Drug Delivery Business News.
The post IBM partners to identify risk factors for Type I diabetes appeared first on MassDevice.
from MassDevice http://ift.tt/2whvev1
Cap comentari:
Publica un comentari a l'entrada